Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.33 USD | +1.22% | -16.78% | -16.70% |
2023 | Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors | CI |
2023 | Angion Biomedia to Implement 10-for-1 Reverse Split | MT |
Financials (USD)
Sales 2021 | 28.31M | Sales 2022 | 2.3M | Capitalization | 24.44M |
---|---|---|---|---|---|
Net income 2021 | -54M | Net income 2022 | -38M | EV / Sales 2021 | 0.1 x |
Net cash position 2021 | 84.09M | Net cash position 2022 | 46.78M | EV / Sales 2022 | -9.71 x |
P/E ratio 2021 |
-1.5
x | P/E ratio 2022 |
-0.63
x | Employees | 8 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 day | -11.51% | ||
Current month | -17.70% | ||
Current year | -17.70% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 8.33 | +1.22% | 21 523 |
24-04-18 | 8.23 | -11.51% | 43,238 |
24-04-17 | 9.3 | -3.43% | 40,605 |
24-04-16 | 9.63 | +4.33% | 29,158 |
24-04-15 | 9.23 | -6.29% | 140,771 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotes- Stock Market
- Equities
- ANGN Stock